1. Home
  2. Labeler Index
  3. Glaxosmithkline Llc
  4. 0173-0915
  5. Product Images: Zejula

Product Images Zejula

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Zejula NDC 0173-0915 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Molecular structure - zejula tab spl graphic 01

Molecular structure - zejula tab spl graphic 01

Figure 1. Progression-Free Survival in Patients with HR-Deficient Tumors (Intent-to-Treat Population, n = 373) - zejula tab spl graphic 02

Figure 1. Progression-Free Survival in Patients with HR-Deficient Tumors (Intent-to-Treat Population, n = 373) - zejula tab spl graphic 02

Figure 2. Progression-Free Surivival in the Overall Population (Intent-to-Treat Population, n=733) - zejula tab spl graphic 03

Figure 2. Progression-Free Surivival in the Overall Population (Intent-to-Treat Population, n=733) - zejula tab spl graphic 03

Figure 3. Progression-Free Survival in the gBRCAmut Cohort Based on IRC Assessment (Intent-to-Treat Population, n = 203) - zejula tab spl graphic 04

Figure 3. Progression-Free Survival in the gBRCAmut Cohort Based on IRC Assessment (Intent-to-Treat Population, n = 203) - zejula tab spl graphic 04

Zejula 100 mg tablet 30 count label - zejula tab spl graphic 05

Zejula 100 mg tablet 30 count label - zejula tab spl graphic 05

Zejula 200 mg tablet 30 count label - zejula tab spl graphic 06

Zejula 200 mg tablet 30 count label - zejula tab spl graphic 06

Zejula 300 mg tablet 30 count label - zejula tab spl graphic 07

Zejula 300 mg tablet 30 count label - zejula tab spl graphic 07